BOSTON — American Medical Association president Bobby Mukkamala defended the restrained advocacy strategy that the country’s largest professional medical organization has taken with the Trump administration during a recent discussion at the STAT Summit. He highlighted the alignment between federal health officials and the AMA on critical issues such as prior authorization, which underscores the organization’s approach to maintaining dialogue with the administration.
Mukkamala acknowledged the potential risks associated with certain Trump administration decisions, such as changes to the childhood vaccine schedule and the proposed overhaul of a key federal advisory panel on preventive services. However, he stressed the necessity of fostering a cooperative relationship with the administration to influence health policy effectively. This stance reflects a broader strategy within the healthcare sector to balance advocacy with pragmatism in a politically charged environment.
Start your 7-day trial and see what the database can do →
